MilliporeSigma Articles
-
The Latest Updates For Sterile Filtration And Single-Use Assemblies
11/5/2026
Revised sterile manufacturing rules shift attention from isolated compliance tasks to evidence that sterility holds across filtration, aseptic connections, single-use systems, and suppliers.
-
Navigating The Analytical Challenges Of Complex ADCs
10/14/2026
Antibody drug conjugates are expanding to deliver diverse therapeutic payloads. Advanced analytical strategies are required to characterize these evolving platforms.
-
High-Performing Ionizable Lipids For Controlled Nucleic Acid Delivery
9/29/2026
Ionizable lipids are central to effective mRNA delivery, influencing potency, biodistribution, and toxicity. See why advancing delivery beyond the liver will require stronger structure-function insights.
-
A Scalable Analytical Method For Quality-Driven AAV Characterization
7/1/2026
AEX-HPLC has emerged as a robust, GMP-compatible analytical method for accurately characterizing AAV capsid composition, enabling consistent assessment of empty, partial, and full capsids to support product quality, process development, and regulatory readiness.
-
Life Cycle Assessment Of Extended Use Strategies For Single-Use Assemblies
4/17/2026
Examine how extending the use of single‑use assemblies can significantly reduce emissions, resource consumption, and waste in bioprocessing, offering a data‑backed path toward sustainability.
-
Biopharma Supply, Reimagined: Regional, Resilient Manufacturing
4/1/2026
Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.
-
A Comprehensive Solution For Adventitious Agent Testing
2/13/2026
Modern sequencing methods offer sensitive detection of adventitious and species‑specific viruses. Learn how targeted and non‑targeted NGS approaches improve confidence in cell bank characterization.
-
Viral Vector Technology Transfers: A Guide To Success
11/13/2025
Strategic, well-aligned partnerships between sponsors and CDMOs are key to efficient, scalable viral vector technology transfer.
-
Streamline Your AAV Process With A Production Platform
10/6/2025
AAVs are reshaping gene therapy, but scaling production introduces complexity. Learn how upstream process optimization can improve yield, consistency, and speed to meet growing demands.
-
Achieve Higher Targeted Concentrations
9/30/2025
Single-pass TFF streamlines downstream processing by reducing footprint, shear exposure, and hold-up volumes. Learn how this approach is advancing efficiency across therapeutic and vaccine production.